You have to be registered and logged in for purchasing articles.
Abstract |
Determination of the Cardiac Glycosides Digoxin and Digitoxin by Liquid Chromatography Combined with Isotope-Dilution Mass Spectrometry (LC-IDMS) - a Candidate Reference Measurement Procedure |
|
This article describes a method of high analytical sensitivity, reproducibility and trueness for the determination of digoxin and digitoxin in serum or plasma at therapeutic levels using a colnbination of high-pressure liquid chromatography (HPLC), isotope-dilution mass spectrometry (IDMS) and caesium-adduct formation. A method for threefold deuterium substitution in the glycosides was developed, which could be performed within 24 hours without distillation giving yields >98% of the theoretical value. Extraction from a serum or plasma matrix was performed using a liquid-phase extraction with ammonium acetate buffer/tertiary butylmethyl ether/ethyl acetate at pH 9.5. The HPLC-separation used a 10 x 2 mm LiChrospher RP-18 5 μm guard column in combination with a 125 x 2 mm main column of the same material and a gradient containing methanol, caesinm ions and formic acid. Quantification of digoxin and digitoxin was made with IDMS using deuterated internal standards and the system run in single ion monitoring (SIM) mode. The methods had a lower limit of determination of 0.25 μg/l for digoxin and digitoxin, a trueness between 97.5 and 104% for digoxin and between 98 and 101 % for digitoxin, respectively and had a coefficient of variation of less than 3% in the therapeutic range for both glycosides. Maximally 1 ml serum or plasma was needed for the procedure. The method is used to set target values for materials used in external quality assessment surveys (EQAS) run by INSTAND as part of a national EQAS-programme. |
|
